Please enable JavaScript to continue using this application.

Compare $FBIO vs $SPRO | Chartloom

Compare

$FBIO vs $SPRO

Fortress Biotech Inc · Spero Therapeutics Inc

FBIO

Fortress Biotech Inc

SPRO

Spero Therapeutics Inc

Compare $FBIO vs $SPRO

Comparing Fortress Biotech Inc and Spero Therapeutics Inc

FBIOFortress Biotech Inc

SPROSpero Therapeutics Inc

FBIOFortress Biotech Inc

Market cap

$71M

P/E (TTM)

0.66x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

15.5%

YTD performance

-47.0%

52W performance

-26.6%

FCF yield

1.8%

SPROSpero Therapeutics Inc

Market cap

$69M

P/E (TTM)

9.42x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-3.3%

YTD performance

-48.9%

52W performance

-47.4%

FCF yield

28.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FBIO

SPRO

Detailed metrics comparison

FBIO

Fortress Biotech Inc

SPRO

Spero Therapeutics Inc

Market Cap

FBIO$71M

SPRO$69M

Enterprise Value

FBIO$-86M

SPRO$19M

Price

FBIO$2.14

SPRO$1.20

P/E Ratio

FBIO0.66x

SPRO9.42x

P/S Ratio

FBIO1.04x

SPRO1.48x

EV/Sales

FBIO-1.26x

SPRO0.40x

EV/EBITDA

FBIO0.00x

SPRO0.78x

P/B Ratio

FBIO0.41x

SPRO1.57x

P/FCF Ratio

FBIO0.56x

SPRO3.55x

EV/FCF

FBIO-0.68x

SPRO0.96x

PEG Ratio

FBION/A

SPRON/A

Forward P/E (NTM)

FBION/A

SPRON/A

Forward P/S (NTM)

FBION/A

SPRON/A

Revenue (TTM)

FBIO$68M

SPRO$47M

Revenue Growth (YoY)

FBIO15.5%

SPRO-3.3%

Forward Rev Growth

FBIO43.7%

SPRO300.0%

Gross Margin (TTM)

FBIO65.6%

SPRO0.0%

Operating Margin (TTM)

FBIO0.0%

SPRO22.1%

EBITDA Margin (TTM)

FBIO-36.1%

SPRO51.2%

Net Margin (TTM)

FBIO151.0%

SPRO15.7%

FCF Margin (TTM)

FBIO183.8%

SPRO41.7%

Net Income (TTM)

FBIO$103M

SPRO$7M

FCF (TTM)

FBIO$126M

SPRO$20M

EPS (TTM)

FBIO$3.25

SPRO$0.13

ROE (TTM)

FBIO103.5%

SPRO16.2%

ROA (TTM)

FBIO43.0%

SPRO12.6%

ROIC (TTM)

FBIO71.7%

SPRO16.2%

Cash

FBIO$197M

SPRO$51M

Debt

FBIO$40M

SPRO$0

Net Cash/Debt

FBIO$157M

SPRO$51M

Current Ratio (TTM)

FBIO3.96x

SPRO6.12x

Quick Ratio (TTM)

FBIO3.76x

SPRO6.03x

Debt/Equity (TTM)

FBIO0.24x

SPRO0.00x

Debt/Assets (TTM)

FBIO0.0%

SPRO0.0%

Interest Coverage (TTM)

FBION/A

SPRON/A

Net Debt/EBITDA (TTM)

FBIO0.00x

SPRO0.00x

Beta

FBIO1.23

SPRO1.54

52W Performance

FBIO-26.6%

SPRO-47.4%

YTD Performance

FBIO-47.0%

SPRO-48.9%

% from 52W High

FBIO-52.9%

SPRO-61.0%

% from 52W Low

FBIO6.7%

SPRO11.1%

Asset Turnover (TTM)

FBIO0.26x

SPRO1.00x

FCF Yield (TTM)

FBIO1.8%

SPRO28.2%

Earnings Yield (TTM)

FBIO145.7%

SPRO10.6%

Dividend Yield (TTM)

FBIO0.7%

SPRON/A

Rule of 40

FBIO199.3

SPRO38.4

EV/GP/RG

FBION/A

SPRON/A

Ticker research

View FBIO research View SPRO research

Metric	FBIO Fortress Biotech Inc	SPRO Spero Therapeutics Inc
Market & Valuation
Market Cap	$71M	$69M
Enterprise Value	$-86M	$19M
Price	$2.14	$1.20
P/E Ratio	0.66x	9.42x
P/S Ratio	1.04x	1.48x
EV/Sales	-1.26x	0.40x
EV/EBITDA	0.00x	0.78x
P/B Ratio	0.41x	1.57x
P/FCF Ratio	0.56x	3.55x
EV/FCF	-0.68x	0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$68M	$47M
Revenue Growth (YoY)	15.5%	-3.3%
Forward Rev Growth	43.7%	300.0%
Profitability
Gross Margin (TTM)	65.6%	0.0%
Operating Margin (TTM)	0.0%	22.1%
EBITDA Margin (TTM)	-36.1%	51.2%
Net Margin (TTM)	151.0%	15.7%
FCF Margin (TTM)	183.8%	41.7%
Net Income (TTM)	$103M	$7M
FCF (TTM)	$126M	$20M
EPS (TTM)	$3.25	$0.13
ROE (TTM)	103.5%	16.2%
ROA (TTM)	43.0%	12.6%
ROIC (TTM)	71.7%	16.2%
Financial Health
Cash	$197M	$51M
Debt	$40M	$0
Net Cash/Debt	$157M	$51M
Current Ratio (TTM)	3.96x	6.12x
Quick Ratio (TTM)	3.76x	6.03x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.23	1.54
52W Performance	-26.6%	-47.4%
YTD Performance	-47.0%	-48.9%
% from 52W High	-52.9%	-61.0%
% from 52W Low	6.7%	11.1%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	1.00x
FCF Yield (TTM)	1.8%	28.2%
Earnings Yield (TTM)	145.7%	10.6%
Dividend Yield (TTM)	0.7%	N/A
Other
Rule of 40	199.3	38.4
EV/GP/RG	N/A	N/A
Ticker research	View FBIO research	View SPRO research

Valuation

P/E Ratio

FBIO

0.66x

SPRO

9.42x

P/S Ratio

FBIO

1.04x

SPRO

1.48x

EV/FCF

FBIO

-0.68x

SPRO

0.96x

Growth & revenue

Revenue Growth TTM

FBIO

15.5%

SPRO

-3.3%

Forward Revenue Growth

SPRO

300.0%

FBIO

43.7%

Profitability & performance

Gross Margin

FBIO

65.6%

SPRO

0.0%

ROE

FBIO

103.5%

SPRO

16.2%

FCF Yield %

SPRO

28.2%

FBIO

1.8%

52-Week Performance

FBIO

-26.6%

SPRO

-47.4%

Detailed metrics comparison

FBIO

Fortress Biotech Inc

SPRO

Spero Therapeutics Inc

Market Cap

FBIO$71M

SPRO$69M

Enterprise Value

FBIO$-86M

SPRO$19M

Price

FBIO$2.14

SPRO$1.20

P/E Ratio

FBIO0.66x

SPRO9.42x

P/S Ratio

FBIO1.04x

SPRO1.48x

EV/Sales

FBIO-1.26x

SPRO0.40x

EV/EBITDA

FBIO0.00x

SPRO0.78x

P/B Ratio

FBIO0.41x

SPRO1.57x

P/FCF Ratio

FBIO0.56x

SPRO3.55x

EV/FCF

FBIO-0.68x

SPRO0.96x

PEG Ratio

FBION/A

SPRON/A

Forward P/E (NTM)

FBION/A

SPRON/A

Forward P/S (NTM)

FBION/A

SPRON/A

Revenue (TTM)

FBIO$68M

SPRO$47M

Revenue Growth (YoY)

FBIO15.5%

SPRO-3.3%

Forward Rev Growth

FBIO43.7%

SPRO300.0%

Gross Margin (TTM)

FBIO65.6%

SPRO0.0%

Operating Margin (TTM)

FBIO0.0%

SPRO22.1%

EBITDA Margin (TTM)

FBIO-36.1%

SPRO51.2%

Net Margin (TTM)

FBIO151.0%

SPRO15.7%

FCF Margin (TTM)

FBIO183.8%

SPRO41.7%

Net Income (TTM)

FBIO$103M

SPRO$7M

FCF (TTM)

FBIO$126M

SPRO$20M

EPS (TTM)

FBIO$3.25

SPRO$0.13

ROE (TTM)

FBIO103.5%

SPRO16.2%

ROA (TTM)

FBIO43.0%

SPRO12.6%

ROIC (TTM)

FBIO71.7%

SPRO16.2%

Cash

FBIO$197M

SPRO$51M

Debt

FBIO$40M

SPRO$0

Net Cash/Debt

FBIO$157M

SPRO$51M

Current Ratio (TTM)

FBIO3.96x

SPRO6.12x

Quick Ratio (TTM)

FBIO3.76x

SPRO6.03x

Debt/Equity (TTM)

FBIO0.24x

SPRO0.00x

Debt/Assets (TTM)

FBIO0.0%

SPRO0.0%

Interest Coverage (TTM)

FBION/A

SPRON/A

Net Debt/EBITDA (TTM)

FBIO0.00x

SPRO0.00x

Beta

FBIO1.23

SPRO1.54

52W Performance

FBIO-26.6%

SPRO-47.4%

YTD Performance

FBIO-47.0%

SPRO-48.9%

% from 52W High

FBIO-52.9%

SPRO-61.0%

% from 52W Low

FBIO6.7%

SPRO11.1%

Asset Turnover (TTM)

FBIO0.26x

SPRO1.00x

FCF Yield (TTM)

FBIO1.8%

SPRO28.2%

Earnings Yield (TTM)

FBIO145.7%

SPRO10.6%

Dividend Yield (TTM)

FBIO0.7%

SPRON/A

Rule of 40

FBIO199.3

SPRO38.4

EV/GP/RG

FBION/A

SPRON/A

Ticker research

View FBIO research View SPRO research

Metric	FBIO Fortress Biotech Inc	SPRO Spero Therapeutics Inc
Market & Valuation
Market Cap	$71M	$69M
Enterprise Value	$-86M	$19M
Price	$2.14	$1.20
P/E Ratio	0.66x	9.42x
P/S Ratio	1.04x	1.48x
EV/Sales	-1.26x	0.40x
EV/EBITDA	0.00x	0.78x
P/B Ratio	0.41x	1.57x
P/FCF Ratio	0.56x	3.55x
EV/FCF	-0.68x	0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$68M	$47M
Revenue Growth (YoY)	15.5%	-3.3%
Forward Rev Growth	43.7%	300.0%
Profitability
Gross Margin (TTM)	65.6%	0.0%
Operating Margin (TTM)	0.0%	22.1%
EBITDA Margin (TTM)	-36.1%	51.2%
Net Margin (TTM)	151.0%	15.7%
FCF Margin (TTM)	183.8%	41.7%
Net Income (TTM)	$103M	$7M
FCF (TTM)	$126M	$20M
EPS (TTM)	$3.25	$0.13
ROE (TTM)	103.5%	16.2%
ROA (TTM)	43.0%	12.6%
ROIC (TTM)	71.7%	16.2%
Financial Health
Cash	$197M	$51M
Debt	$40M	$0
Net Cash/Debt	$157M	$51M
Current Ratio (TTM)	3.96x	6.12x
Quick Ratio (TTM)	3.76x	6.03x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.23	1.54
52W Performance	-26.6%	-47.4%
YTD Performance	-47.0%	-48.9%
% from 52W High	-52.9%	-61.0%
% from 52W Low	6.7%	11.1%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	1.00x
FCF Yield (TTM)	1.8%	28.2%
Earnings Yield (TTM)	145.7%	10.6%
Dividend Yield (TTM)	0.7%	N/A
Other
Rule of 40	199.3	38.4
EV/GP/RG	N/A	N/A
Ticker research	View FBIO research	View SPRO research